AAAAAA

   
Results: 1-25 | 26-50 | 51-57 |
Results: 51-57/57

Authors: Steinberg, SM Swallow, CE Ma, WK
Citation: Sm. Steinberg et al., Vapor phase sorption of benzene by cationic surfactant modified soil, CHEMOSPHERE, 38(9), 1999, pp. 2143-2152

Authors: Freifeld, A Marchigiani, D Walsh, T Chanock, S Lewis, L Hiemenz, J Hiemenz, S Hicks, JE Gill, V Steinberg, SM Pizzo, PP
Citation: A. Freifeld et al., A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy, N ENG J MED, 341(5), 1999, pp. 305-311

Authors: Lee, KH Wang, E Nielsen, MB Wunderlich, J Migueles, S Connors, M Steinberg, SM Rosenberg, SA Marincola, FM
Citation: Kh. Lee et al., Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but doesnot lead to tumor regression, J IMMUNOL, 163(11), 1999, pp. 6292-6300

Authors: Chougnet, C Fowke, KR Mueller, BU Smith, S Zuckerman, J Jankelevitch, S Steinberg, SM Luban, N Pizzo, PA Shearer, GM
Citation: C. Chougnet et al., Protease inhibitor and triple-drug therapy: cellular immune parameters arenot restored in pediatric AIDS patients after 6 months of treatment, AIDS, 12(18), 1998, pp. 2397-2406

Authors: Bauer, KS Kohn, EC Lush, RM Steinberg, SM Davis, P Kohler, D Reed, E Figg, WD
Citation: Ks. Bauer et al., Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: Use of a single model for simultaneous determination of changing parameters, J PHAR BIOP, 26(6), 1998, pp. 673-687

Authors: Foster, CB Lehrnbecher, T Mol, F Steinberg, SM Venzon, DJ Walsh, TJ Noack, D Rae, J Winkelstein, JA Curnutte, JT Chanock, SJ
Citation: Cb. Foster et al., Host defense molecule polymorphisms influence the risk for immune-mediatedcomplications in chronic granulomatous disease, J CLIN INV, 102(12), 1998, pp. 2146-2155

Authors: Jarrard, JA Linnoila, RI Lee, HR Steinberg, SM Witschi, H Szabo, E
Citation: Ja. Jarrard et al., MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis, CANCER RES, 58(23), 1998, pp. 5582-5589
Risultati: 1-25 | 26-50 | 51-57 |